Cite
HARVARD Citation
Mu, S. et al. (2021). Human Mass Balance and Metabolite Profiling of [14C]‐Pamiparib, a Poly (ADP‐Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer. Clinical pharmacology in drug development. 10 (9), pp. 1108-1120. [Online].